Norton Healthcare and UofL Physicians – Pediatrics Integration

In October 2019, Norton Healthcare, UofL Physicians – Pediatrics and the University of Louisville School of Medicine officially signed a definitive agreement for a new affiliation. This resulted in the formation of Norton Children’s Medical Group, which will assume operations March 1, 2020, for all existing UofL Physicians – Pediatrics offices, including employing clinical office staff and providers.

We are committed to innovation and education. With this new initiative, Norton Healthcare’s support of UofL’s clinical research and the medical school’s academic mission will continue. These entities collectively recognize the importance of teaching the next generation of pediatric providers, as well as the importance of UofL’s research mission, in growing a regionally and nationally recognized pediatric program.

“Norton Healthcare and the University of Louisville have a long-standing relationship in pediatric services,” said Russell F. Cox, president and CEO of Norton Healthcare. “Our dedicated providers work side by side every day at Norton Children’s Hospital to ensure that our community’s children receive the quality health care they deserve.”

This is just the beginning! We are investing in technology. Future enhancements will include developing an access center so one phone number will get you the referral you need.

As the March 1 integration date approaches, our teams are actively working to make the transition as seamless as possible for your patients.

What This Integration Means

  • Improved access. We are committed to improving access and getting your patients in to see a provider faster. We are actively recruiting more than 50 specialists toward this goal.
  • Improved care coordination. As of March 1, each patient’s health records (inpatient and outpatient) will be part of Epic, an integrated electronic medical records system. This will improve care coordination and our communication with you, especially through Epic Link, a secure web-based tool that provides real-time access to view your patients’ clinical information.
  • New multidisciplinary clinics. New clinics will be added to allow more children to receive the coordinated care they need. We have already opened a Congenital Diaphragmatic Hernia Clinic and Bowel Management Clinic. Examples of upcoming clinics include:
    • Aerodigestive Clinic
    • Feeding Tube Clinic
    • Vascular Malformation Clinic
    • Neurofibromatosis Clinic
    • Baclofen Pump Clinic
    • Craniosynostosis Clinic
    • Extremely Low Birth Weight Clinic
    • Eosinophilic Esophagitis Clinic
    • Severe Asthma Clinic
    • Oncofertility Clinic
    • Craniofacial Clinic

Integration Questions

Learn more about the affiliation that will combine resources to strengthen and enhance medical care for children.

Our Leadership

Learn more about Norton Healthcare executive leaders, medical leaders and board members who provide focused strategic direction that helps to better serve our community.

Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.

Subscribe

Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Keith A. McLean, M.D.

Norton Heart & Vascular Institute welcomes Keith A. McLean, M.D., cardiologist; office hours dedicated to residents of Madison and surrounding communities.

Read More

Shawn W. Adams, M.D., joins Norton Leatherman Spine

After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]

Read Full Story

Tzield may delay Stage 3 Type 1 diabetes in adults and children

Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]

Read Full Story

Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology

Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]

Read Full Story

DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases

Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]

Read Full Story

Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment

Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]

Read Full Story

Search our entire site.